Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input

Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH (2022) and K K Y Ho “Clinical Biology of the Pituitary Adenoma " Endocr Rev 43(6):1003–1037

Google Scholar 

Calvanese F, Jacquesson T, Manet R, Vasiljevic A, Lasolle H, Ducray F, Raverot G (2022) Jouanneau. “Neoadjuvant B-Raf and mek inhibitor targeted therapy for adult Papillary Craniopharyngiomas: a New Treatment paradigm. Front Endocrinol (Lausanne) 13:882381

Article  PubMed  Google Scholar 

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A (2018) “Correction To: Criteria for the Definition of Pituitary Tumor Centers of Excellence (Ptcoe): A Pituitary Society Statement.“ Pituitary 21, no. 6 : 663

留言 (0)

沒有登入
gif